E. Coli Vaccine Study

Now Enrolling in Binghamton, Grand Island, Norfolk, San Diego, and Vestal

Now Enrolling

About this research study

Escherichia coli (E. coli) are bacteria that can cause infections, which can trigger diarrhea, nausea, vomiting, and fever. In some cases, the infection can be life-threatening. While E. coli can affect people of all ages, people age 60 and older are more susceptible to becoming ill from the bacteria, especially those with a history of urinary tract infections (UTIs).

Velocity is now seeking participants ages 60 and older with a history of UTI for an investigational E. coli vaccine study.

Eligible participants...

  • Must be ages 60 or older
  • Must have had a documented case of UTI within the past 2 years
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Binghamton, New York • Velocity Clinical Research

1130 Upper Front St., Binghamton, NY 13905
Phone: (607) 800-5777

Grand Island, Nebraska • Velocity Clinical Research

3537 West 13th St., Ste. 100, Grand Island, NE 68803
Phone: (308) 365-8900

Norfolk, Nebraska • Velocity Clinical Research

3400 W Norfolk Avenue, Norfolk, NE 68701
Phone: (402) 371-0797

San Diego (La Mesa), California • Velocity Clinical Research

5565 Grossmont Center Dr Building 2, Suite 1, La Mesa, CA 91942
Phone: (619) 567-1550

Vestal, New York • Velocity Clinical Research

4100 Vestal Road, Ste LL-100, Vestal, NY 13850
Phone: (607) 794-5790

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy